Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
Institut Gustave Roussy · HM Hospitales · +19 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,175
total citations
- FWCI
- 58.21
- Percentile
- 100%
- References
- 148
Citations per year
Authors
22Topics & keywords
Topics
Keywords
- Medicine
- Oncology
- Internal medicine
- Pembrolizumab
- Cancer
- Precision medicine
- Immunotherapy
- Pathology
No related works found for this paper.
Funding
- AAmgen
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- SSanofi
- FHF. Hoffmann-La Roche
- LLLes Laboratories Pierre Fabre
- COClovis Oncology
- IIncyte
- RTRelay Therapeutics
- PBPuma Biotechnology
- APAstellas Pharma
- ESEuropean Society for Medical Oncology
- SServier
- CPChugai Pharmaceutical
- FMFoundation Medicine
- NCNIH Clinical Center